Skip to content

IAS: DART trial shows AZT/3TC/tenofovir effective in majority after one year

North Indians have naturally lower CD4 cell counts: implications for treatment decisions

Proof-of-concept study shows benefits of Kaletra / efavirenz combination

HAART during primary HIV infection restores interferon production

Response to HAART improves due to better drugs and more expertise in their use

BMJ editorial: assess cardiovascular risk and consider delaying HAART until CD4s reach 200 cells/mm3

Low level and intermittent HIV replication during very early infection

HIV-1 and HIV-2 coinfection: viral response to HAART differs

Total lymphocyte count, anaemia, add to symptoms in pinpointing who needs treatment in Thailand